Hepatitis C: all 2,356 studies
Page 2 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
- A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVCompletedNCT05904470Phase 2Results posted
- Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral TherapyTerminatedNCT05717400Phase 4Results posted
- Linkage to Care for Persons With Hep C InfectionCompletedNCT05397067Not applicableResults posted
- Criminal Justice Coordinated Transitional CareCompletedNCT05376371Not applicableResults posted
- Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)CompletedNCT04903626Phase 3Results posted
- Tajik Migrant Health Education StudyCompletedNCT04853394Not applicableResults posted
- TeleHepC Treatment TrialCompletedNCT04798521Not applicableResults posted
- Hepatitis C Pharmacy-based Strategy for InjectorsCompletedNCT04698629Results posted
- Rapid HCV Treatment Access for Persons Who Use DrugsCompletedNCT04677153Not applicableResults posted
- Supporting Treatment Outcomes Among PWIDCompletedNCT04652804Not applicableResults posted
- Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic DonorsCompletedNCT04575896Phase 4Results posted
- QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/PibrentasvirTerminatedNCT04515797Phase 4Results posted
- Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless AdultsCompletedNCT04513899Not applicableResults posted
- Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)CompletedNCT04427202Not applicableResults posted
- Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/VelpatasvirCompletedNCT04382404Phase 1Results posted
- Coaching for HCV and HIVCompletedNCT04314414Not applicableResults posted
- Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3CompletedNCT04268173Not applicableResults posted
- Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT04211909Phase 3Results posted
- Hepatitis C-Video vs. Brochure Education DeliveryCompletedNCT04204447Not applicableResults posted
- Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)CompletedNCT04134767Not applicableResults posted
- Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated CirrhosisCompletedNCT04112303Phase 3Results posted
- Association of Hepatitis C Virus With Breast CancerCompletedNCT04090164Results posted
- Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus InfectionCompletedNCT04042740Phase 2Results posted
- Mobile Enhanced Prevention Support for People Leaving JailCompletedNCT04036396Not applicableResults posted
- The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment StudyCompletedNCT03987503Phase 4Results posted
- The Kentucky Viral Hepatitis Treatment StudyCompletedNCT03949764Phase 4Results posted
- Reaching mEthadone Users Attending Community pHarmacies With HCVCompletedNCT03935906Not applicableResults posted
- HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS FunctionCompletedNCT03902366Results posted
- eHealth Partnered Evaluation Initiative - Evaluation of the Initial Deployment of VA's Annie Texting SystemCompletedNCT03898349Not applicableResults posted
- Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C EradicationCompletedNCT03823911Phase 4Results posted
- Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) InfectionTerminatedNCT03820258Phase 2Results posted
- The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant RecipientsCompletedNCT03819322Phase 2Results posted
- Utilization of Hepatitis C Positive Kidneys in Negative RecipientsCompletedNCT03801707Phase 2/3Results posted
- Multi-center Study to Transplant Hepatitis-C Infected KidneysCompletedNCT03781726Phase 4Results posted
- Transplanting Hepatitis C Lungs Into Negative Lung RecipientsCompletedNCT03724149Phase 1/2Results posted
- Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCVCompletedNCT03652675Not applicableResults posted
- HCV Seek, Test and Rapid Treatment for Young PWIDCompletedNCT03627546Not applicableResults posted
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive DonorsCompletedNCT03627299Phase 4Results posted
- Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung TransplantTerminatedNCT03625687Phase 4Results posted
- Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney TransplantCompletedNCT03619837Phase 4Results posted
- Universal HIV Screening and Targeted HCV Screening in Emergency DepartmentCompletedNCT03595527Not applicableResults posted
- Building on Needle Exchange to Optimize Prevention & TreatmentCompletedNCT03567174Not applicableResults posted
- Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)CompletedNCT03537274Phase 2/3Results posted
- Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicableResults posted
- A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With MavyretCompletedNCT03523871Phase 2Results posted
- Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active InfectionCompletedNCT03512210Phase 4Results posted
- Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)CompletedNCT03501550Phase 2Results posted
- Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) InfectionTerminatedNCT03487848Phase 2Results posted
- Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]CompletedNCT03480932Phase 2/3Results posted
- Helping Empower Liver and Kidney PatientsCompletedNCT03426787Not applicableResults posted
- An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis CCompletedNCT03423641Results posted
- A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis CCompletedNCT03420768Phase 2Results posted
- EBR/GZR for HCV-1b Patients Receiving HemodialysisCompletedNCT03420300Phase 4Results posted
- Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)CompletedNCT03379506Phase 2Results posted
- Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis CCompletedNCT03365635Phase 4Results posted
- Computer-based Intervention for Alcohol-using HIV/HCV+ WomenCompletedNCT03362476Not applicableResults posted
- A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV StudyCompletedNCT03236506Phase 2Results posted
- Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
- A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction ClinicCompletedNCT03235154Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCompletedNCT03219216Phase 3Results posted
- Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)CompletedNCT03214679Not applicableResults posted
- Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1CompletedNCT03212521Phase 3Results posted
- DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart TransplantTerminatedNCT03208244Phase 4Results posted
- DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver TransplantTerminatedNCT03208127Phase 4Results posted
- Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA TreatmentTerminatedNCT03207399Phase 4Results posted
- Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)CompletedNCT03146741Phase 1/2Results posted
- A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus ElbasvirCompletedNCT03144635Phase 4Results posted
- Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDsCompletedNCT03127358Not applicableResults posted
- Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF)CompletedNCT03126370Phase 4Results posted
- Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionCompletedNCT03119025Phase 1/2Results posted
- Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment StudyCompletedNCT03118843Phase 3Results posted
- Harvoni Treatment Porphyria Cutanea TardaCompletedNCT03118674Phase 2Results posted
- Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C PatientsCompletedNCT03117569Phase 3Results posted
- Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)CompletedNCT03111108Phase 4Results posted
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of CareCompletedNCT03093415Phase 4Results posted
- Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV SubjectsCompletedNCT03092375Phase 3Results posted
- A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisCompletedNCT03089944Phase 3Results posted
- 'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'CompletedNCT03088917Results posted
- Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03074331Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal ImpairmentCompletedNCT03069365Phase 3Results posted
- A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03067129Phase 2/3Results posted
- Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C InfectionCompletedNCT03057847Phase 4Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian FederationCompletedNCT03053180Results posted
- Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036852Phase 2Results posted
- Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036839Phase 2Results posted
- Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV InfectionCompletedNCT03022981Phase 2Results posted
- Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC TaiwanCompletedNCT03020095Phase 2Results posted
- Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China IIICompletedNCT03020082Phase 3Results posted
- Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China IICompletedNCT03020004Phase 2Results posted
- Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)CompletedNCT03002818Results posted
- Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisCompletedNCT02996682Phase 3Results posted
- Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisCompletedNCT02994056Phase 2Results posted
- A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naiveCompletedNCT02993250Phase 2Results posted
- Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe FibrosisCompletedNCT02973503Phase 3Results posted
- The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWIDCompletedNCT02971488Results posted
- Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis CTerminatedNCT02971033Phase 2Results posted
- Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality InterventionCompletedNCT02970136Not applicableResults posted
- A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 InfectionCompletedNCT02966795Phase 3Results posted